Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 25, 2017
Jaguar Health announced its wholly-owned subsidiary, Napo Pharmaceuticals, has entered into a Termination, Asset Transfer and Transition Agreement with India-based Glenmark Pharmaceuticals.
read more
Monday, September 25, 2017
Atox Bio today announced that it has been awarded the next option on a performance-based contract with the BARDA for the development of Reltecimod in patients with NSTI.
read more
Monday, September 25, 2017
Geisinger and Boehringer Ingelheim announced a collaboration to develop a risk-prediction model for three critical health outcomes commonly associated with type 2 diabetes that have long-term impact.
read more
Wednesday, August 30, 2017
Cambrex, announced it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq.ft. analytical laboratory.
read more
Wednesday, August 16, 2017
A market evaluation by Future Market Insights highlights the small molecule API market in a new research study.
read more
SK Capital has signed a definitive agreement to acquire Perrigo API business.
read more
Aerie Pharmaceuticals has received notification by its contract drug product manufacturer that the contract manufacturer has received a CRL from the FDA regarding the contract manufacturer’s NDA for one of their own product candidates.
read more
Wednesday, August 09, 2017
Cambrex Corporation announced that it is to invest $24 million in a new facility to manufacture highly potent APIs (HPAPIs) at its Charles City, Iowa plant.
read more
Avara Pharmaceutical Services has signed an agreement with Pfizer to acquire the Liscate, Italy sterile manufacturing facility.
read more
CMP Pharma announced the FDA has granted final approval of the company’s New Drug Application for CaroSpir.
read more
Thursday, August 03, 2017
Moderna announced Juan Andres has joined the company as Senior Vice President of Late Stage Technical Development and Manufacturing (beyond human proof of concept).
read more
STA Pharmaceutical, a WuXi AppTec group company, has merged with WuXi AppTec’s Pharmaceutical Development Services division.
read more
Ginkgo Bioworks and Swissaustral announced a new partnership to design strains of microorganisms that will produce industrial enzymes at scale.
read more
Powder containment and aseptic transfer valve specialist ChargePoint Technology is expanding its U.S. presence, following a multi-million-pound investment from LDC.
read more
Adimab has entered into an agreement with Eli Lilly to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas.
read more